Food Safety Incidents

Suggestion of therapeutic properties has been detected in Dietary supplement glamorous shape.

Written by SGS Digicomply Editorial Team | Feb 27, 2026 11:00:00 PM

Incident Report: Dietary Supplement Safety Concern

On February 12, 2026, a significant food safety incident was reported concerning a dietary supplement known for its glamorous shape. This incident originated in Brazil and was identified by the Brazilian Health Regulatory Agency (ANVISA).

The primary concern raised involves the suggestion of therapeutic properties associated with this dietary supplement. Such claims can pose serious risks to consumers, as they may lead individuals to believe that the product can treat or prevent health conditions without sufficient scientific evidence to support these assertions.

It is crucial for consumers to be aware of the potential dangers linked to dietary supplements that make unverified health claims. Regulatory agencies play a vital role in monitoring and controlling the safety and efficacy of these products to ensure public health is not compromised.

As a precaution, consumers are advised to consult healthcare professionals before incorporating any dietary supplements into their routine, particularly those that claim therapeutic benefits. Additionally, it is important to stay informed about product recalls or safety alerts issued by health authorities.

This incident underscores the importance of regulatory oversight in the dietary supplement industry and the need for consumers to exercise caution when considering products that may not have undergone rigorous scientific evaluation.

  • Incident: Suggestion of therapeutic properties has been detected in Dietary supplement glamorous shape.
  • Date: 2026-02-12
  • Product: Dietary supplement glamorous shape
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA